CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease - Test2 - elhamkhani - TriplyDB

CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease

CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease

http://www.wikidata.org/entity/Q33760744

about

Blood alpha-synuclein in agricultural pesticide handlers in central Washington State Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis Brain-gut-microbiota axis in Parkinson's disease Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities The role of DNA methylation in aging, rejuvenation, and age-related disease Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro Mosaicism of alpha-synuclein gene rearrangements: report of two unrelated cases of early-onset parkinsonism.Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases The MethDet: a technology for biomarker development Advances in epigenetics and epigenomics for neurodegenerative diseases.DNA methylation dynamics in plants and mammals: overview of regulation and dysregulation.Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review Epigenetic mechanisms governing the process of neurodegeneration.Chromatin deregulation in disease.Epigenetics-Based Therapeutics for Neurodegenerative Disorders.Methylation status of DJ-1 in leukocyte DNA of Parkinson's disease patients.Complex Effects of the ZSCAN21 Transcription Factor on Transcriptional Regulation of α-Synuclein in Primary Neuronal Cultures and in Vivo Alpha-Synuclein Expression in Patients with Parkinson's Disease: A Clinician's Perspective.Up-regulation of SNCA gene expression: implications to synucleinopathies DNA methylation, a hand behind neurodegenerative diseases.Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes.Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson's disease.Opening up the DNA methylome of dementia A novel tool for monitoring endogenous alpha-synuclein transcription by NanoLuciferase tag insertion at the 3'end using CRISPR-Cas9 genome editing technique.Genetic variability in SNCA and Parkinson's disease.Emerging roles of epigenetic mechanisms in Parkinson's disease.DNA methylation as a biomarker for neuropsychiatric diseases.α-Synuclein in Parkinson's disease.α-Synuclein and neuronal cell death.The potential of epigenetic therapies in neurodegenerative diseases Recent advances in biomarkers for Parkinson's disease focusing on biochemicals, omics and neuroimaging.The prion hypothesis of Parkinson's disease.Parkinson's disease is associated with DNA methylation levels in human blood and saliva.

P2860

Q23922069-09196581-6B27-42CB-AA06-EDED4A7627AC Q26744563-DAA48261-5F66-4391-B1CF-1681EDD9D270 Q26771812-4046DE0C-CD68-459A-AD4F-888D5F2902FC Q26774368-2358EB2E-5354-4738-A52A-EE9D0DA856A9 Q26784403-300B4EC4-494C-46E1-B949-58FF92098AD3 Q26821835-8C469864-35E8-4943-8F9E-74E41F3BEEB7 Q27023811-CDC10160-DD7F-461C-9B80-EC30553E6263 Q27025194-0BF8142D-4051-4225-971E-74542E749189 Q28547585-34E0C27F-8A66-4697-9515-CB8C42F4DCEC Q33740695-EFE5BD29-B3B3-4AB7-8B79-B023FC5959ED Q33818001-F5E1695A-25A1-4232-A80C-A5899CEBB623 Q34342813-F189C1D5-F9B0-4AB0-B4A9-5BDD4CD4E2C4 Q34504712-8CD810A0-3970-4009-8BF1-AA4269EA033A Q34685028-17C06D1C-D56D-4F24-8FD5-52A1BAEEE991 Q35597591-C89E8A35-F185-493E-891A-5B8DBA4DC588 Q35709124-D07CCC0D-BFDB-4809-8B4D-7759CF7848A7 Q35966485-17FEB5C6-1C80-4F99-9934-42C7CACEB9C5 Q36020884-E9D137C1-37C7-42A5-8636-CB4D5181603B Q36223734-B36765C2-03E2-4A8B-AEEF-247FCAF59A26 Q36405886-79B0A7A4-BA35-4CE4-9867-7FEEBCEEB7EC Q36599581-8FF4DD87-9D3A-4E7F-8A90-EFC246F89CD0 Q36697733-8346C5B4-D48B-489A-A992-14B462F4F7A1 Q36748749-9A7A5B53-4B10-4473-A67C-7E4FDC3CD9C9 Q36884715-06FBB47A-B7AB-408D-B75C-E6839D126CCC Q36976868-A62BFB5A-C143-4C8C-A4BE-1885574B1914 Q37004246-3A275BF6-6923-4637-9EB2-9038FC3AF8E0 Q37365439-CAD5A73D-4FF5-4A07-82D9-B49A7606C42E Q37478171-7E7F0BFF-870C-4516-9553-E8B5A2EF5EFB Q37631054-690FE6DD-6A6B-48A9-B2E7-B650C6CA0E88 Q37736146-49773B3F-716A-48C3-B311-432E44A70312 Q37736517-81820A6F-8F81-4DF2-8E20-C62028B42D11 Q37907930-762E4BC3-18E3-45AE-90B3-FCF6FABC6496 Q37926552-5DFF8ABC-281A-4CF7-9A65-67E2EDF61570 Q37960643-CA3E4390-5B32-48CF-B876-D3C8E5F110E2 Q37987146-D7372638-65BA-4903-9707-89FD4F9A76A8 Q38039369-7D471A3C-6283-4416-AA31-F34BA716D0D2 Q38234971-32277636-0BEF-499F-85EC-7E17CF9295A1 Q38315590-A96DDA3D-F54E-4501-947D-311125ABD3E4 Q38418624-C27CC334-314F-4AA6-B1DC-9B8F9228F60B Q38603331-C3C12B84-B9DA-4540-8F6B-CCAB0FF067C0

P2860

CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease

http://www.wikidata.org/entity/Q33760744

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

CpG demethylation enhances alp ...... genesis of Parkinson's disease

@ast

CpG demethylation enhances alp ...... genesis of Parkinson's disease

@en

type

label

CpG demethylation enhances alp ...... genesis of Parkinson's disease

@ast

CpG demethylation enhances alp ...... genesis of Parkinson's disease

@en

prefLabel

CpG demethylation enhances alp ...... genesis of Parkinson's disease

@ast

CpG demethylation enhances alp ...... genesis of Parkinson's disease

@en

P1433

Q33760744-1356B77A-8132-4811-94A4-BF4383816FFF

P1476

Q33760744-F53F15ED-C1D6-4B33-8FF9-1C54E3999E34

P2093

Q33760744-10251B01-8A4C-4819-B081-356A551D8DB0

Q33760744-1110CF0C-3F37-44FF-826F-BFDA3C9FCEAD

Q33760744-11DEDE8E-0C69-431E-8348-D860CD05D44F

Q33760744-4942C75E-54B9-4DC1-8375-E4780DFFC4A3

Q33760744-CBFD9D0B-B246-4B67-8FB1-D40AE41FD340

Q33760744-D53803B2-1CFB-409C-A151-5C08DE202483

P2860

Q33760744-0E990EAC-9824-4770-980B-BB9A8A3D7268

Q33760744-0F1E8A24-A6C8-496F-AAA5-F26E4430536D

Q33760744-0F40D65F-8253-461D-BF78-5F98EA4DDB19

Q33760744-2001BC37-D451-43BD-A8AF-29F7B4798191

Q33760744-270405E9-8616-4B7E-9A8E-09567A6A0F42

Q33760744-3756EB06-3840-4B2E-92AE-0E8C85488068

Q33760744-5266EEB0-B300-43B0-801B-638A0658D8EB

Q33760744-54801E28-1F9C-4058-8513-9E0AEB46CD26

Q33760744-599BBAF9-AF15-47C4-BC2B-CB4D1ADE90A2

Q33760744-5D34C305-94F1-4785-BF7A-C3ECDE676B26

P304

Q33760744-17FE8007-04E8-4E57-89C5-D5DB8BDB3A16

P31

Q33760744-74D2ADB4-47E1-45D5-A9CF-3741D55C8452

P356

Q33760744-05138FB8-2D37-4053-BB4E-0F2DF10C3F4F

P407

Q33760744-D6C9EF00-FC6F-43CE-A1DD-2994D0A26101

P433

Q33760744-28E0FD44-1EEE-4F69-A552-7ECBAA9FB3F3

P478

Q33760744-7DF14FE5-3293-4129-8A03-DEC77F95CC43

P50

Q33760744-BA4471D0-2D37-4BD7-B9CB-4B6C86B1052F

P577

Q33760744-8BB75715-A1CC-47FE-8E6A-6888423DF0BC

P5875

Q33760744-D068AF4F-C965-496F-BE61-20D1AE33195A

P698

Q33760744-949B7E86-0FF9-4DA3-BF03-153DD1412C16

P921

Q33760744-338E992E-1B63-43FF-8914-64F012BA7530

Q33760744-D55E388D-3AF5-425C-94F2-01260D2D739B

P932

Q33760744-E9A52BCF-42EA-49F6-80A3-519ED02B8F28

P356

JOURNAL.PONE.0015522

P1433

P1476

CpG demethylation enhances alp ...... genesis of Parkinson's disease

@en

P2093

Akira Tamaoka

http://www.w3.org/2001/XMLSchema#string

Hidetoshi Date

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kurisaki

http://www.w3.org/2001/XMLSchema#string

Hiroshi Takuma

http://www.w3.org/2001/XMLSchema#string

Lumine Matsumoto

http://www.w3.org/2001/XMLSchema#string

Shoji Tsuji

http://www.w3.org/2001/XMLSchema#string

P2860

Upregulation of alpha-synuclein by lipopolysaccharide and interleukin-1 in human macrophages

Functional dissection of the alpha-synuclein promoter: transcriptional regulation by ZSCAN21 and ZNF219

High sensitivity mapping of methylated cytosines

alpha-Synuclein locus triplication causes Parkinson's disease

Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies

Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

Epidemiology of Parkinson's disease

CpG island methylator phenotypes in aging and cancer.

P304

e15522

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0015522

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49651865

http://www.w3.org/2001/XMLSchema#string

P698

21124796

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2991358

http://www.w3.org/2001/XMLSchema#string